These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38827327)

  • 1. Knockdown of HE4 suppresses tumor growth and invasiveness in lung adenocarcinoma through regulation of EGFR signaling.
    Zhang Y; Yang W; Han X; Qiao Y; Wang H; Chen T; Li T; Ou WB
    Oncol Res; 2024; 32(6):1119-1128. PubMed ID: 38827327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Akt kinase LANCL2 functions as a key driver in EGFR-mutant lung adenocarcinoma tumorigenesis.
    Lou Y; Xu J; Zhang Y; Zhang W; Zhang X; Gu P; Zhong H; Wang H; Lu J; Han B
    Cell Death Dis; 2021 Feb; 12(2):170. PubMed ID: 33568630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plakophilin-2 accelerates cell proliferation and migration through activating EGFR signaling in lung adenocarcinoma.
    Hao XL; Tian Z; Han F; Chen JP; Gao LY; Liu JY
    Pathol Res Pract; 2019 Jul; 215(7):152438. PubMed ID: 31126818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleophosmin promotes lung adenocarcinoma cell proliferation, migration and invasion by activating the EGFR/MAPK signaling pathway.
    Li M; Wu R; Zhu D; Wang L; Liu S; Wang R; Deng C; Zhang S; Chen M; Lu R; Zhu H; Mo M; Luo Z
    Oncol Rep; 2023 Jun; 49(6):. PubMed ID: 37165929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD73 (NT5E) Promotes the Proliferation and Metastasis of Lung Adenocarcinoma through the EGFR/AKT/mTOR Pathway.
    Zhang H; Cao Y; Tang J; Wang R
    Biomed Res Int; 2022; 2022():9944847. PubMed ID: 35813221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mex3a interacts with LAMA2 to promote lung adenocarcinoma metastasis via PI3K/AKT pathway.
    Liang J; Li H; Han J; Jiang J; Wang J; Li Y; Feng Z; Zhao R; Sun Z; Lv B; Tian H
    Cell Death Dis; 2020 Aug; 11(8):614. PubMed ID: 32792503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STAMBP promotes lung adenocarcinoma metastasis by regulating the EGFR/MAPK signaling pathway.
    Xu H; Yang X; Xuan X; Wu D; Zhang J; Xu X; Zhao Y; Ma C; Li D
    Neoplasia; 2021 Jun; 23(6):607-623. PubMed ID: 34102455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of ERO1L attenuates tumor growth, migration and invasion in lung adenocarcinoma through Wnt/β‑catenin pathway.
    Zhang S; Zhang M; Ma W; Wang L; Yu B
    Biotechnol Genet Eng Rev; 2024 Nov; 40(3):1910-1923. PubMed ID: 37014092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DEPDC1B is a Novel Direct Target of B-Myb and Contributes to Malignant Progression and Immune Infiltration in Lung Adenocarcinoma.
    Zuo X; Wang D; Tao C; Dou X; Zhao Z; Zhang J; Huang S; Li Y; Zhang X; Bu Y; Wang Y
    Front Biosci (Landmark Ed); 2024 May; 29(6):204. PubMed ID: 38940035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APE1 stimulates EGFR-TKI resistance by activating Akt signaling through a redox-dependent mechanism in lung adenocarcinoma.
    Lu GS; Li M; Xu CX; Wang D
    Cell Death Dis; 2018 Oct; 9(11):1111. PubMed ID: 30382076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
    Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
    J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GLUT1 promotes cell proliferation via binds and stabilizes phosphorylated EGFR in lung adenocarcinoma.
    Zhou Z; Li Y; Chen S; Xie Z; Du Y; Liu Y; Shi Y; Lin X; Zeng X; Zhao H; Chen G
    Cell Commun Signal; 2024 Jun; 22(1):303. PubMed ID: 38831321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DUS4L suppresses invasion and metastasis in LUAD via modulation of PI3K/AKT and ERK/MAPK signaling through GRB2.
    Li Z; Zhao PL; Gao X; Li X; Meng YQ; Li ZQ; Zhai KR; Wei SL; Feng HM; Huang HR; Li B
    Int Immunopharmacol; 2024 Dec; 142(Pt A):113043. PubMed ID: 39216120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
    Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y
    Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIF-1α-HPRT1 axis promotes tumorigenesis and gefitinib resistance by enhancing purine metabolism in EGFR-mutant lung adenocarcinoma.
    Geng P; Ye F; Dou P; Hu C; He J; Zhao J; Li Q; Bao M; Li X; Liu X; Xu G
    J Exp Clin Cancer Res; 2024 Sep; 43(1):269. PubMed ID: 39343971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAR2 promotes tumor-associated angiogenesis in lung adenocarcinoma through activating EGFR pathway.
    Li Y; Huang H; Chen X; Yu N; Ye X; Chen L; Huang Z
    Tissue Cell; 2022 Dec; 79():101918. PubMed ID: 36148733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NOTCH3 Overexpression and Posttranscriptional Regulation by miR-150 Were Associated With EGFR-TKI Resistance in Lung Adenocarcinoma.
    Zhang Y; Chen B; Wang Y; Zhao Q; Wu W; Zhang P; Miao L; Sun S
    Oncol Res; 2019 Jul; 27(7):751-761. PubMed ID: 30732676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis.
    Jiang L; Wang R; Fang L; Ge X; Chen L; Zhou M; Zhou Y; Xiong W; Hu Y; Tang X; Li G; Li Z
    Theranostics; 2019; 9(9):2460-2474. PubMed ID: 31131047
    [No Abstract]   [Full Text] [Related]  

  • 19. C1orf74 positively regulates the EGFR/AKT/mTORC1 signaling in lung adenocarcinoma cells.
    Guo J; Li A; Guo R; He Q; Wu Y; Gou Y; Jin J; Huang G
    PeerJ; 2022; 10():e13908. PubMed ID: 36032960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SMC2 knockdown inhibits malignant progression of lung adenocarcinoma by upregulating BTG2 expression.
    He Y; Wang Y; Luo Z; Zhang X; Bai H; Wang J
    Cell Signal; 2024 Aug; 120():111216. PubMed ID: 38729325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.